David Skromne Kadlubik, Aguilar RR, Chávez DR, Enciso MJM, Hernández GH, Meaney ME, Mendirichaga OR, Shuchleib CR, Teniente VR

Language: Spanish
References: 15
Page: 224-234
PDF size: 154.83 Kb.

Text Extraction

No abstract

REFERENCES

1. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22(S): 6A-13A.

2. Eriksson H. Heart failure: a growing public health problem. J Intern Med 1995; 237: 135-141.

3. American Heart Association. 1998 Heart and Stroke Statistical Update. Dallas Tx: American Heart Association; 1997.

4. O’Connell JB, Bristow MR. Economic impact of heart failure in the United States: Time for a different approach. J Heart Lung Transplant 1994; 13: S107-S112.

5. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management. Am Heart J 1997; 133: 703-712.

6. Packer M. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20 248-254.

7. Massie BM. 15 years of heart-failure trial: What have we learned? Lancet 1998; 352 (suppl 1): 29-33.

8. Packer M. How should physician view heart failure. The philosophical and physiological evolution of the conceptual models of the disease. Am J Cardiol 1993: 71(S): 3C-11C.

9. Packer M. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248-254.

10. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990; 81: 1161-1172.

11. Cohn JN. Structural basis for heart failure: Ventricular remodeling and its pharmacologic inhibition. Circulation 1995; 91: 2504-2507.

12. Packer M. How should physician view heart failure? The philosophical and physiological evolution of the conceptual models of the disease. Am J Cardiol 1993: 71: C3-C11.

13. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996; 93: 1677-1676.

14. Hasking GJ, Esler MD, Jennings GL, Burton D, Kormer PI. Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615-621.

15. Givertz MM, Colucci WS. New targets for heart-failure therapy: Endothelin, inflammatory cytokines, and oxidative stress. Lancet 1998; 352: 34-38.